Search - tctmd.com

Displaying 321 - 340 of 406

Sort: Relevancy | Date

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

News Daily News

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

December 05, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Caitlin E. Cox

July 25, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

News Daily News

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

L.A. McKeown

July 05, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

Advertisement

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content